A therapeutical method for treating chronic arteriosclerosis obliterans in particularly selected patients with severely disabling intermittent claudication is disclosed, which comprises administering propionyl L-carnitine or a pharmacologically acceptable salts thereof.
The present invention discloses a method for treating a subject suffering from intermittent claudication (IC) wherein said subject takes an effective dose of propionyl L-carnitine or a pharmaceutically acceptable salt thereof and also engaging in a concomitant physical training program. The method is particular effective for patients with intermittent claudication at class II of the Leriche-Fontaine's classification. The method provides a relief from peripheral arterial disease symptoms, as shown by claudication-limited exercise tolerance, while also improving quality of life.
